| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |